Target intelligence / Profile preview

Plasmodium falciparum DNA damage-inducible protein 1 (PfDdi1)

Target
PfDdi1
Molecular classification
Enzyme, Aspartic protease, Retropepsin, Proteasome-interacting protein
01

Overview

Plasmodium falciparum DNA damage-inducible protein 1 (PfDdi1) is an essential retropepsin (A2 family aspartic protease) that serves as a critical component of the parasite's ubiquitin-proteasome system (UPS) and unfolded protein response (UPR) (Onchieku et al., 2021; Arora et al., 2023). It functions as a proteasome shuttle protein, facilitating the degradation of polyubiquitinated substrates and the repair of DNA-protein crosslinks (DPCs) (Arora et al., 2023; Oduro-Kwatenga et al., 2025). PfDdi1 is indispensable for the survival and development of the malaria parasite across its life cycle stages (Arora et al., 2023). Recent research has identified PfDdi1 as a primary target of artemisinin and its derivatives, which inhibit its proteolytic activity and lead to the toxic accumulation of damaged proteins and DNA (Onchieku et al., 2021; Oduro-Kwatenga et al., 2025). The inhibition of PfDdi1 results in the accumulation of toxic protein aggregates and unrepaired DNA damage, which are lethal to the parasite (Onchieku et al., 2021). Furthermore, its retroviral-like protease (RVP) domain makes it a potential target for HIV protease inhibitors like lopinavir, offering a novel avenue for antimalarial drug development and combination therapies to combat drug-resistant malaria (Arora et al., 2023; UniProt Q8IM03). This target is particularly attractive due to its essentiality and the presence of a unique protease fold that may allow for selective inhibition over human homologs (Onchieku et al., 2021).

Other names
PfDDI1DNA damage-inducible protein 1Proteasome shuttle proteinRetropepsinRetroviral-like aspartic proteaseA2 family aspartic protease
02

Mechanism of action

Inhibition of PfDdi1 protease activity leads to the accumulation of polyubiquitinated proteins and DNA-protein crosslinks, causing cellular toxicity and parasite death.

03

Biological functions

Proteasomal degradationDNA damage repairUnfolded protein responseProtein homeostasis
04

Disease associations

Infection
05

Safety considerations

Artemisinin resistanceTarget specificity (human DDI1/DDI2)Cross-resistance
06

Interacting drugs

Artemisinin

6 more in the full profile.

07

Biomarkers

Polyubiquitinated protein accumulationDNA-protein crosslinksDNA fragmentationNuclear recruitment of PfDdi1

Beyond the preview

Go deeper on Plasmodium falciparum DNA damage-inducible protein 1 (PfDdi1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum DNA damage-inducible protein 1 (PfDdi1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call